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Phenotypic and functional aspects of melanoma-
hyaluronate interactions were investigated by studying the 
expression of CD44, cell migration, .and transmembrane 
penetration of human melanoma cellimes on hyaluronate-
coated substrates. Expression of CD44 was tested by flow 
cytometry on seven human melanoma cell lines. Strong reac-
tivity with anti-CD44 monoclonal antibody was observed in 
four of seven of the cell lines. Migration studies of CD44(+) 
cell lines on hyaluronic acid- and chondroitin-6-sulfate-
coated substrates, using time-lapse video-microscopy, 
showed a dramatic dose-dependent increase in migration rate 
on hyaluronate but not on chondroitin-6-sulfate. Moreover, 
CD44(-) cell lines showed no modification in migration rate 
on either substrate. Addition of soluble hyaluronate produced 
a dose-dependent inhibition of acceleration of CD44(+) cells 
T he interaction of cancer cells with extracellular matrix (ECM) components through specific cell surface re-ceptors is believed to play a role in the invasive or migratory behavior of the cells and involves the cyto-skeleton via signal transduction [1-6]. The cell sur-
face glycoprotein CD44, expressed on many cell types, is reported 
to playa role in cell-ECM relationships and cell-cell interactions 
mainly through its action as a receptor for the glycosaminoglycan 
hyaluronic acid [7 -13]. Two major forms of CD44 have been de-
scribed. The "hematopoietic" form, CD44H, is expressed on lym-
phocytes and various other cell types of mesodermal origin and 
strongly binds hyaluronic acid. The "epithelial" form, CD44E, is 
expressed in some epithelial cells and various carcinomas and has a 
lower affinity for surface-bound hyaluronic acid [14]. Several mela-
noma cell lines have been shown to express CD44H [12,13]. 
Human CD44 has recently been shown to increase the tumorigenic 
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Abbreviations: 
BSA: bovine serum albumin 
CD44E: epithelial form of CD44 
CD44H: hematopoietic form of CD44 
CD44Rg: CD44 receptor globulin 
ECM: extracellular matrix 
MEM: minimal essential medium 
MFI: mean fluorescence intensity 
MoAb: monoclonal antibody 
PBS: phosphate-buffered saline 
on hyaluronate-coated substrates, whereas addition of chon-
droitin-6~sulfate had no effect. Migration inhibition experi-
ments with soluble CD44 (CD44 receptor globulin) also 
showed specific blocking of the migration of CD44(+) cells 
on hyaluronate. Haptotactic invasion was increased in 
CD44(+) cell lines through hyaluronate-coated polycarbon-
ate membranes, whereas no change was detected on 
chondroitin-6-sulfate - coated membranes. CD44( -) cell 
lines showed no. response to either type of coating. In the 
melanoma cell hnes tested, the expression of CD44 corre-
lated with illl/itro migration and invasiveness on hyaluronate 
substrates. Taken together, our data are consistent with the 
suggest~on that CD44 may playa role in stimulating in vivo 
aggressiveness of tumors through hyaluronate-rich stroma. 
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potential oflymphoma cells [15], whereas the rodent homologue of 
CD44 has b.een observed ~o confer m.etastatic potential to epithelial 
tumor cell hnes [16]. AdditIOnal studies have suggested a direct link 
between the expressIOn of CD44 and tumor aggressiveness [17-
19]. !he hy~luron~te receptor has been ~uggested to be closely 
assoCIated with .actln ~lament~ througl~ ItS cytoplasmic domain 
[?O-23],.whlch IS cO~~lst~nt with a role 1Il cell motility and migra-
non. Active cell motlhty IS thought to playa role in the metasta-
sizing process on the basis of.observations that ECM components, 
such as type IV collagen, lamll1l1l, or fibronectin, may enhance cell 
adhesion and/or migration [24-32]. 
Several lines of evidence suggest that the interaction between 
hyaluronate and its cell surfa.ce receptor, CD44, may stimulate 
tumor aggreSSlveness. Synth~SIS of hyaluronic acid, the CD44 lig-
and, has been shown t? be stimulated by invading tumor cells as a 
result of tumor-cell II1teractlon with host tissue stromal cells 
[33,34]. The presence of a loose coat of hyaluronic acid around the 
~ost agg.ress~ve .muri~e melanoma tumors is believed to be permis-
sive for III VIVO lIlVaSIVeness [35], and locomotion of transformed 
cells has been shown to be related to the presence of hyaluronic acid 
[36]. 
In this work, we investigated the migratory and haptotactic inva-
sive response of human melanoma cell lines to hyaluronate-coated 
substrates. Our observations suggest that both migratory and hapto-
tactic properties of melanoma cells in the presence of hyaluronate 
are directly related to CD44 expression. 
MATERIALS AND METHODS 
Melanoma Cell Culture Seven melanoma cell lines were iso-
I~ted in perman.ent culture as previously described [37]. Briefly, cell 
lll1e~ were obtall1ed .by explant cultures from sterile, fresh surgical 
speCImens of one pnmary melanoma from patient WK, two recur-
0022-202X/93/$06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. 
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Figure 1. Flow-cytometry detennination of the CD44 phenotype of 
seven human melanoma cell lines after staining with the FIO-442 anti-
CD44 MoAb. Note that three metastatic-derived cell lines (A, C, D) and 
one recurrent cutaneous melanoma-derived cell line (B) express CD44, 
whereas one primary melanoma-derived cell line (E) , one recurrent cuta-
neous melanoma-derived cell line (G) , and one metastatic-derived cell 
Line (F) are CD44(-). See text for mean and mode fluorescence intensity 
values. 
rent cutaneous melanomas from patients MC and EP, and four 
metastatic melanomas from patients BP, RU, AN, and LH and 
respectively coded PM-WK, RPM-MC, RPM-EP, MM-BP, MM-
RU, MM-AN, and MM-LH. The cell lines were characterized by 
their reactivity with S-100 (DAKO, Santa Barbara, CA) and/or 
HMB-45 (Enzo Diagnostics, N ew York, NY) antibodies. Cells 
were maintained in permanent culture in minimal essential medium 
(MEM) with Earles balanced sal t solution, 2% fetal calf serum, 8% 
newborn calf serum, and 0.5% gentamicin (Gibco, Inc., Grand Is-
land, NY). The cultures were passed, at subconfluence, approxi-
mately once a week and kept in a 5% CO2 and 95% air humidified 
atmosphere. 
Flow Cytometry. Expression of CD44 Melanoma cells were 
obtained in suspension after trypsinization of the subconfluent cul-
tures and were incubated for 30 min at 4°C with F10-44Z anti-
CD44 monoclonal antibody (MoAb) (Accurate Chemicals Corp., 
Westbury, NY) at 1 : 500 dilution, washed in phosphate-buffered 
saline (PBS) , incubated with fluorescein-labeled goat -anti-mouse 
antiserum (Cappel, Malvern, PA) 1: 40 dilution for 30 min, and 
analyzed with a Becton Dickinson (Mountain View, CA) FACScan 
cytometer. Fl 0-442 MoAb cross-reacts with both CD44E and 
CD44H [1 5]. 
Migration Assays Coated substrates were obtai~ed follo,:,,"ing 
the procedures described by Goodman et at [25] With slight modifica-
tions. Briefl y, sterile glass coverslips were incubated for 6 h at 4 ° C 
in 35-mm petri dishes containing 1 ml of a solution of hyaluronic 
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MM-BP on BSA only 
(13.2 ± 8.2 ~m/hr) 
MM-BP on Hval. ac. 0.05 mglml. 
(28.1 f 6.8 ~m/hr) 
MM-BP on Chond-6-S. 5 mglml 
(10.7 ± 6.2 Ilm/hr) 
MM-BP on Hyal. ac. 5 mglml 
(30 .5 ± 6 ~m/hr) 
100 ~m 
Figure 2. "Spider" diagram representation of the migration pathways 
for 3 h of a representative CD44(+) cell line (MM-BP) on heat-denatured 
BSA- coated, chondroitin-6-sulfate (Chond-6-S)-coated, and hyal-
uronic acid (Hyal. ac.)-coated substrates. Note the dramatic increase of 
the migration distances on hyaluronate-coated substrates compared Wlth 
denatured BSA. Chondroitin-6-sulfate-coated coverslips do not enhance 
the migratory behavior of the melanoma cells. 
acid at concentrations of 0.05,0.5, or 5 mg/ml in PBS or a solution 
of chondroitin-6-sulfate (Na salt from shark carti lage C4384; 
Sigma Chemical Co., St. Louis, MO) at concentrations of 0.05,0.5 , 
or 5 mg/ ml in PBS. The coverslips were then washed twice with 
PBS, incubated 12 h at 4 ° C in heat-denatured bovine serum albu-
min (BSA) [A7906 (Sigma), 20 mg/ml, 80 °C for 20 min], and 
washed twice with PBS. Control coverslips were treated by dena-
tured BSA only. 
Migration assays were performed as described previously with 
slight modifications [37]. Briefly, subconfluent cultures of PM-
WK, RPM-EP, MM-BP, MM-RU, and MM-LH were treated with 
0.02% ethylenediaminetetraacetic acid (EDT A), and one drop of a 
106 cells/ml suspension was placed in the center of the coated co-
verslip immersed in a 10% serum-containing medium to obtain a 
cell density between 0.4 and 1.0 cells/l04 f,J.m2 • After a minimum of 
4 h of incubation (37 °C, 5% CO2 , 95% air), cell migration was 
studied over a 3-h period under a Nikon Diaphot inverted micro-
scope with a lOX phase-contrast objective in an attached, henneti-
cally sealed Plexiglass Nikon NP-2 incubator at 37°C in a 5% CO2 
and 95% air environment. Cell migration was recorded using a 
Dage-MTI 65DX video camera and a Hitachi TLC1550 time-lapse 
videocassette recorder. Image analysis was performed by playing 
back the video images, digital saving of images at hours 0, 1, 2, and 
3, and tracing the migration paths of individual cells on the video 
monitor. Migration rate was defined by the algebraic sum of the 
hourly two-dimensional migration distances divided by 3 h, result-
ing in micrometers/hour values. Migration of at least 35 cells was 
analyzed for each experimental condition. Image analysis was 
carried out with the Microcomp image analysis system (Southern 
Micro Instruments, Atlanta, GA), a Numonic digitablet , a high-re-
solution video monitor (Sony, New York, NY), and an IBM-com-
patible personal computer (Samsung S500) equipped with a video 
card (personal computer vision plus frame grabber; Imaging T ech-
nology, Woburn, MA). The data were saved as an MS-DOS (Mi-
crosoft) fil e and translated through a network (TOPS; Sun Micro-
system Co., Berkeley, CA) to a Macintosh SE for statistical analysis. 
Normalized migration paths were obtained, using graphic com-
puter software, by "grabbing" individual cell paths and "dragging" 
them without rotation so that the origins of all paths were superim-
posed on one central point. 
Migration Inhibition Assays with Soluble Hyaluronate Cell 
suspensions of RPM-EP, MM-RU, and MM-BP were plated on 
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Figure 3_ Migration assay, including three CD44(:-) (A-C) ~nd two 
CD44(-) (D and E) cell lines o~ substrates coated With pro~esslve con-
centrations of hyaluronic aad (Hyal. ac.) or chondrOltin-6-sulfate 
(Chond-6-S) and on control co~ted with denatured B?A ~nly .. Note that 
the three CD44(+) cell lines sigruficantly enhanced thelf ffilgration rate on 
hyaluronate- but not on chondroitin-coated surfaces and that no accelera-
tion occurred on both substrates with the CD44(-) cells. Error bars repre-
sent standard deviation of migration rates of greater than 30 cells and do 
not represent standard error of the m~a.n; therefore th~ ba~s appear large. 
However, because the number of mdiVldual cells studied m each expen-
mental condition is greater than 30, the t statistic is also relatively large; 
thus the asterisks represent significance at p < 0.001 in comparison with 
controls. 
sterile coverslips coated with a 5-mg/ml solution ofhyal.uronic acid 
and heat-denatured BSA and incubated for 4 h as descn~ed abo~e. 
The medium was removed, the coverslip washed two times .w.lth 
PBS, and hyaluronic acid- or chondroitin-6-sulfate-conta111111g 
medium (at concentrations of 0.01, 0.1, and 1 mg/ml) was tra~~­
ferred into petri dishes. The preparation was ~llovo.:ed to re-eqUlll-
brate for 25 min at 37"C, 5% CO2 , and the migration pathways of 
the cells were recorded and analyzed as described above. 
Migration Inhibition Assays with Soluble CD44 Rec~pt~r 
Globulin To further determine the role of CD44 expreSSIon 111 
melanoma cell migration, we performed migration-blocking ex-
periments using a soluble form of CD44 rec.eptor gl?bull.n 
(CD44Rg). This prot~in is the res~ l t of construction of chlmenc 
CD44 immunoglobul1l1 cDNA fUSIOns and subsequent fuslOnl?ro-
tein production, as recently described in detail [7]. CD44Rg b111ds 
hyaluronate in vitro and irl vivo [7]. As descnbed above, cell suspen-
sions of RPM-EP, MM-RU, and MM-BP were plated on 5 mg/ml 
hyaluronate-coated covers lips and incubated 4 h. Then the medium 
was removed, the preparation washed twice, and a soluble 
CD44Rg-containing medium at 25 )lgjml w~s added . The l:"'rep~ra­
tion was allowed to re-equilibrate for 25 mm, and the nugratlon 
rates were obtained as described above. 
Transmembrane Haptotactic Invasion Assays Our ~tudy of 
transmembrane haptotactic invasion of the ~elanoma ce~11111es f?l-
lowed the procedures described by Aznavoonan et af [3] With modlfi-
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cations. Haptotaxis is defined by the migration of the cells in a 
concentration dependent manner on insoluble step gradients of sub-
stratum bound attractants [3]. Modified Boyden chambers (Trans-
well 24, 8-)lm pore, 3422; COSTAR, Cambridge, MA) were coated 
on the bottom side of the polycarbonate membrane by overnight 
flotation of the upper chamber units on solutions of hyaluronic acid 
or chondroitin-6-sulfate (at concentrations of 0.05, 0.5, and 5 mg/ 
ml in PBS) at 37"C. Control units were floated on PBS alone. Each 
experimental condition was studied in triplicate. The two sides of 
each membrane were washed three times with PBS and 105 cells in 
susperision after 0.02% EDT A treatment of the PM-WK, RPM-EP, 
MM-LH, MM-RU, and MM-BP subconfluent cultures were im-
planted into each upper chamber unit and incubated for 24 h at 
37°C in a 5% CO2 humidified atmosphere. Each side of the mem-
brane was then washed three times with PBS; the unit was fixed for 
10 min inl0% formalin, treated for 5 min with 0.5% TritonX-100 
(T6878; Sigma), and stained by Gill's hematoxylin. Membranes 
were removed and mounted on glass slides. All preparations were 
observed under a standard microscope with a 40X objective. Mi-
grated cells on the opposite side of the filter from the plating side 
were counted in five randomly determined high-power fields. 
RESULTS 
CD44 Expression in Melanoma Cells Expression of CD44 on 
melanoma cell lines was assessed by flow-cytometry analysis of cells 
incubated with the FI0-442 anti-CD44 MoAb. Strong CD44 ex-
pression was shown on the MM-BP, RPM-EP, MM-RU, and MM-
AN human melanoma cell lines (Fig lA-D), with mean fluores-
cence intensity (MFI) values of348, 195,206, and 213, respectively. 
On the other hand, PM-WK, MM-LH, and RPM-MC cell lines 
were found to be CD44(-) (Fig. lE- G), with MFI values of 50, 54, 
and 39, respectively. Control staining with the fluorescent-labeled 
secondary antibody alone for each cell line was performed (data not 
shown), and MFI values obtained ranged from 26 to 50, similar to 
the CD44(-) MFI values. 
Migration of Melanoma Cells on Hyaluronate-Coated Sub-
strates Is Related to CD44 Expression Migration of five mela-
noma cell lines on substrates coated with three progressive concen-
trations of hyaluronic acid or chondroitin-6-sulfate was compared, 
and "spider" diagrams of the migration pathways were obtained by 
superposition, as. outlined in Materials and Methods (Fig 2). Although 
different migration rates are observed among the cell lines on the 
control denatured BSA-coated substrates, each cell line served as its 
own control; accordingly, a dose-dependent acceleration of the mi-
gration rate within a cell line can be interpreted as an effect of the 
substrate. As seen in Fig 3, among the three CD44(+) cell lines, 
MM-BP exhibited a statistically significant (p < 0.001) increase in 
migration rate on substrates coated with hyaluronic acid at low, 
intermediate, and high concentrations, RPM-EP at intermediate 
and high concentrations, and MM-RU at the highest coating con-
centration only. Error bars in Fig 3 represent standard deviation of 
migration rates of greater than 30 cells and do not represent standard 
error of the mean; therefore, they appear large. However, because 
the number of individual cells studied in each experimental condi-
tion is greater than 30, the t statistic is also relatively large; thus, the 
asterisks represent significance at p < 0.001. No significant modifi-
cation of migratory behavior of any of the cell lines occurred on 
chondroitin-6-sulfate -coated substrates (Fig 3A - C). 
The two CD44(-) cell lines PM-WK and MM-LH showed no 
significant acceleration of their migration rates on ei ther hyaluronic 
acid- or chondroitin-6-sulfate-coated substrates (Fig 3D and E). 
Soluble Hyaluronate Inhibits the Migratory Response of 
CD44(+) Melanoma Cells on Hyaluronate-Coated Sub-
strates FI0-442 anti-CD44 MoAb does not interfere with CD44 
binding to hyaluronate [13]. We therefore designed an inhibition 
assay with soluble hyaluronate, the specific ligand of CD44, by 
analogy with previous studies of the cell-ECM interactions [3] . 
Migration inhibition assays were performed on three CD44(+) mel-
anoma cell lines on the highest coating concentrations of hyal-
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Figure 4_ Representative migration inhibition assay of a CD44(+) cell 
line (RPM-EP) by addition of soluble hyaluronic acid, chondroitin-6-sul-
fate, or soluble CD44Rg to a cell preparation on substrates coated with 5 
mg/ml of hyaluronic acid. Note that hyaluronate in solution progres-
sively suppresses the high-concentration, substrate-bound hyaluronic 
acid-induced migration acceleration in a significant dose-dependent 
manner. Chondroitin-6-sulfate at matched concentrations had no effect. 
Soluble CD44Rg also significantly abrogates the hyaluronate-dependent 
acceleration of the migration. Error bars, standard deviation of migration 
rates of greater than 30 cells (Op < 0.001). 
uronic acid (5 mg/ml), judged the most favorable condition for 
migration acceleration in t~e pr~vious set of .e~periments . . After 
addition of soluble hyaluronic aCid or chondrOltm-6-sulfate In the 
experimental medium, the migration rate was determined as de-
scribed above by image analysis. The statistical analysis was per-
formed by a Student t test comparing the inhibition assays with a 
control, on the same coating concentration, without addition of 
soluble glycosaminoglycan. The increase in the migration rate of 
the three CD44(+) cell lines RPM-EP, MM-RU, and MM-BP ob-
served on hyaluronic acid - coated substrates was inhibited in a dose-
dependent manner by the addition of hyaluronic acid in solution 
into the experimental medium. No modification occurred with the 
chondroitin-6-sulfate-containing media (Fig 4). 
Migration of CD44(+) Melanoma Cells on Hyaluronate Is 
Blocked by Soluble CD44Rg To further demonstrate the speci-
ficity of the CD44-dependent acceleration of the migration rate of 
CD44(+) melanoma cells on hyaluronate, we conducted blocking 
assays using a soluble form of CD44, as described in Materials and 
Methods. Soluble CD44 (CD44Rg) has been previously shown to 
bind hyaluronate in vivo and in vitro [7]. In these experiments, the 
migration rate of our three CD44(+) melanoma cells was tested on 
5-mg/ml hyaluronate-coated surfaces in the presence of CD44Rg 
at a concentration of25 f.1g/mi. The CD44-expression-dependent 
migration on hyaluronate was found to be completely abrogated by 
soluble CD44Rg (Fig 4). 
Melanoma Cell Haptotactic Invasiveness Through Hyaluro-
nate-Coated Membranes Is Related to CD44 Expression 
We investigated the transmembrane haptotactic invasion in modi-
fied Boyden chambers with 8-f.1m-pore polycarbonate membranes 
that were coated on the bottom side with hyaluronic acid or chon-
droitin-6-sulfate. The three CD44(+) cell lines RPM-EP, MM-
RU, and MM-BP exhibited a statistically significant (p < 0.001) 
increase in their transmembrane migration rate through hyaluronic 
acid-coated membranes when compared with uncoated controls 
(Fig SA-C). No modification occurred with the chondroitin-6-
sulfate - coated membranes. The two CD44(-) cell lines PM-WK 
and MM-LH showed no modification of their transmembrane mi-
gration rate on either hyaluronic acid- or chondroitin-6-sulfate-
coated membranes (Fig 5D and E). 
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Figure 5. Transmembrane haptotactic invasion assay of three CD44(+) 
(A-C) and two CD44(-) (D and E) human melanoma cell lines. Note 
that the transmembrane migration of the CD44(+) cells is significantly 
enhanced through the membranes coated with hyaluronate (Hyal. ac.) on 
the opposite side of the plating but not through the chondroitin-6-sulfate 
(Chond-6-S)-coated membranes. CD44(-) cells did not modify their 
invasive behavior on both types of coated membranes. Error bars, standard 
deviation of counts obtained from five high-power fields (H.P.F.) ("p < 
0.001). 
DISCUSSION 
Malignant cells interact with the ECM components through spe-
cific receptors, resulting in the generation of signals that stimulate 
the cells to modify their spreading and motility. Some of the modifi-
cations acquired as a result of interactions with ECM components 
are believed to playa role in tumor progression [4,5] . The cell 
surface receptors for ECM components have been the object of 
intense study in vivo and in vitro, and some of them, including CXJjI 
integrin [38], CX4PI integrin [1], and P3-integrin subunit [1] have 
been identified as markers of melanoma progression. 
In addition to a variety of glycoproteins, ECM contains variable 
quantities of glycosaminoglycans. Glycosaminoglycans are poly-
meric chains of disaccharide subunits and include chondroitin sul-
fate, dermatan sulfate, keratan sulfate, heparan sulfate, heparin, and 
hyaluronate [39,40]. Glycosaminoglycans are found to be abnor-
mally synthesized by tumor cells [35] or by fibroblasts of the host 
tissue stroma in reaction to stimulation by tumor cells [34]. Re-
cently, glycosaminoglycans have been suggested to playa role in 
tumor aggressiveness in vivo [33]. Hyaluronate synthesis and deposi-
tion have been found to be significantly increased in stroma of the 
highly invasive murine B16-FI0 melanoma when compared with 
B16-F1 tumors, which display lower invasiveness [35]. No single 
cell surface receptor has been shown to be related to melanoma 
invasion, but several studies have demonstrated positive correlations 
between expression of receptors for ECM components and tumor 
progression in melanomas II ,38,41 ,42]. 
Hyaluronic acid has recently been shown to be a ligand of CD44, 
a widely distributed cell surface glycoprotein [9,11,13,14]. CD44 is 
expressed on normal melanocytes both in culture and in situ (L. 
Thomas, unpublished data). In this study, we show that the expres-
sion of the hyaluronate receptor CD44 is heterogeneous among 
human melanoma cell lines and that high expressers of CD44 have a 
greater migratory and invasive potential on hyaluronate-coated 
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substrates. Our study suggests that CD44 may playa role in the 
relationship between melanoma cells and host tissue stroma. In-
deed, a recent study showing that the most aggressive murine mela-
nomas are surrounded by a coat of hyal uronate suggests a permissive 
role of this tumor microenvironment in neoplastic invasion [35]. 
The intracellular domain of CD44 is know n to be closely asso-
ciated to the cytoskeleton and more specifically to actin filaments 
[10,20 - 23]. The organization of actin cytoskeleton into stress fiber 
arrays correlates with random migration of melanoma cells [37]. 
The association of actin filaments with the hyaluronate receptor 
may suggest a role for its ligand in the cytoskeletal rearrangement 
during active cell migration, possibly by a signal-transducing effect. 
Several studies have suggested that the presence of soluble ECM 
ligands may inhibit cell attachment or migration on ECM sub-
strates. Examples include the inhibition of the binding of fibronec-
tin on Cl'3fll-integrin by soluble ARG-GL V-ASP peptide in vitro 
[3,24] and with the ill vivo reduction of the metastasizing potential 
of cells pre-treated with the YIGSR pentapeptide, which binds to 
the laminin receptors [26]. Consistent w ith these observations, our 
data suggest that only the substrate-bound form of hyaluronic acid is 
able to enhance CD44(+) cell migration. This condition is probably 
more closely reminiscent of ill vivo conditions because most ECM 
hyal uronate is thought to be bound to proteoglycans and link pro-
teins [39,40] . Last, th e specificity of inhibition by h yaluronic acid 
and not by chondroitin-6-sulfate is in agreement with previous 
studies describing a higher affinity of CD44 for hyaluronate than 
for chondroitin sulfate [7,11,14,44]. 
To further characterize the specificity of the CD44-dependent 
acceleration of the migration rate on hyaluronate, we conducted 
blocking experiments with soluble chimeric CD44 immunoglobu-
lin fusion protein (CD44Rg) . The affinity of this protein for hyal-
uronate in vivo and ill vitro has been previously described [7]. The 
dramatic inhibition that we observed further demonstrates the speci-
ficity of the effect of CD44 as a hyaluronate receptor in the migra-
tion of cells on coated hyaluronate and is in agreement w ith 
previous studies describing the high affinity of CD44Rg for hyal-
uronate [7]. . 
Transmembrane haptotactic invasion assays can be considered a 
reference method for the study of cell migration ill vitro [3,32,45] . 
Our data on CD44 expression and motility have to be integrated 
into the context of ECM - cancer cell interactions and can be com-
pared with the interactions of melanoma cells w ith a substitute of 
the basement membrane [32] or the enhanced invasiveness induced 
by laminin, fibronectin, and type IV collagen ill vitro [3]. 
The present observations provide direct evidence that hyaluronic 
acid, through interaction with CD44, stimulates migration and 
haptotactic invasiveness of melanoma cell lines ill vitro and suggest 
that these structures may play an important role in the invasive and 
metastatic behavior o f melanomas ill vivo. Finally, we have recently 
transfected one of our CD44(-) lines, obtained a number of 
CD44(+) clones, and observed significant increase in motility on 
hyaluronate substrates [46]. These data support recent studies show-
ing that rat carcinoma cells acquire a metastatic potential when 
transfec ted with a CD44 variant [16] and that CD44H-transfected 
lymphomas display enhanced tumorigenicity [15] . 
This work was supported iI' part by "10 Bou rse Marc Chaplal de Recherche Derma-
tologique" (Frallce) (LT) alld by NIH gra llts CA-55735 (IS) alld CA-45587 
(HRB) . 
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